RNA Synthetase Inhibitor Antibacterial [EPC]

RNA Synthetase Inhibitor Antibacterial [EPC] was reported 13871 times

Drugs of the RNA Synthetase Inhibitor Antibacterial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VAGINAL FLATULENCE 164 0.5413
1 NASAL VESTIBULITIS 17 0.1700
2 PURPURA SENILE 13 0.1066
3 BURKHOLDERIA TEST POSITIVE 13 0.1048
4 FEMALE GENITAL TRACT FISTULA 173 0.1012
5 RADICULOPATHY 175 0.0663
6 MACULAR DEGENERATION 760 0.0636
7 CHRONIC SINUSITIS 226 0.0602
8 PROCTITIS 165 0.0588
9 MATERNAL CONDITION AFFECTING FOETUS 12 0.0543
10 TARSAL TUNNEL SYNDROME 11 0.0500
11 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 48 0.0452
12 HUMIDITY INTOLERANCE 17 0.0425
13 TERATOGENICITY 12 0.0397
14 INTERCEPTED PRODUCT PRESCRIBING ERROR 42 0.0317
15 HYPERPARATHYROIDISM SECONDARY 72 0.0287
16 NEPHROGENIC ANAEMIA 122 0.0263
17 SEBORRHOEIC KERATOSIS 28 0.0193
18 REBOUND ACID HYPERSECRETION 57 0.0188
19 FOLATE DEFICIENCY 20 0.0173
20 VAGINAL DISCHARGE 166 0.0164
21 NASAL DISCHARGE DISCOLOURATION 22 0.0159
22 PARAESTHESIA ORAL 226 0.0157
23 IMPETIGO 23 0.0154
24 CLEFT LIP AND PALATE 17 0.0152
25 RESORPTION BONE INCREASED 12 0.0146
26 BONE DEMINERALISATION 15 0.0142
27 ORAL CANDIDIASIS 185 0.0140
28 TRACHEITIS 10 0.0131
29 BODY TEMPERATURE ABNORMAL 24 0.0130
30 SKIN WEEPING 45 0.0126
31 CUTANEOUS T-CELL LYMPHOMA 14 0.0111
32 INFUSION SITE DISCHARGE 19 0.0108
33 GROIN ABSCESS 12 0.0102
34 INFUSION SITE BRUISING 22 0.0102
35 END STAGE RENAL DISEASE 185 0.0101
36 INFUSION SITE MASS 11 0.0101
37 ANAEMIA OF CHRONIC DISEASE 9 0.0100
38 ASPERGILLOSIS 13 0.0099
39 RHINALGIA 27 0.0098
40 TOOTH EROSION 12 0.0098
41 STAPHYLOCOCCAL SKIN INFECTION 12 0.0098
42 PERIRECTAL ABSCESS 10 0.0090
43 VESTIBULAR DISORDER 11 0.0090
44 XEROSIS 11 0.0089
45 LUMBAR RADICULOPATHY 10 0.0086
46 LINEAR IGA DISEASE 14 0.0084
47 SINUS OPERATION 20 0.0084
48 FOOD AVERSION 14 0.0082
49 PROCEDURAL PAIN 219 0.0079
50 SEBORRHOEIC DERMATITIS 13 0.0079
51 CHRONIC KIDNEY DISEASE 582 0.0077
52 INFUSION SITE PRURITUS 24 0.0076
53 PRODUCT PRESCRIBING ISSUE 162 0.0074
54 SKIN INFECTION 80 0.0071
55 FREQUENT BOWEL MOVEMENTS 188 0.0070
56 PUSTULE 16 0.0067
57 NASAL SEPTUM DEVIATION 13 0.0066
58 ESSENTIAL HYPERTENSION 12 0.0066
59 SKIN WOUND 11 0.0065
60 VERTIGO POSITIONAL 11 0.0063
61 DERMAL CYST 15 0.0061
62 RECALLED PRODUCT ADMINISTERED 57 0.0060
63 INGROWING NAIL 14 0.0059
64 NEURODERMATITIS 22 0.0059
65 COLITIS 212 0.0056
66 CHEILITIS 29 0.0054
67 HORDEOLUM 23 0.0053
68 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 91 0.0053
69 THROMBOPHLEBITIS SUPERFICIAL 16 0.0053
70 PAPULE 37 0.0052
71 APPLICATION SITE PAIN 115 0.0052
72 STAPHYLOCOCCAL INFECTION 169 0.0051
73 SEASONAL ALLERGY 72 0.0051
74 SKIN ABRASION 24 0.0051
75 PARANASAL SINUS DISCOMFORT 19 0.0050
76 RECTAL HAEMORRHAGE 215 0.0050
77 SKIN HAEMORRHAGE 74 0.0050
78 CLOSTRIDIUM TEST POSITIVE 11 0.0050
79 MULTIPLE ALLERGIES 39 0.0050
80 SKIN FISSURES 97 0.0050
81 WOUND COMPLICATION 17 0.0049
82 EYELID PAIN 10 0.0049
83 ANHEDONIA 129 0.0049
84 DEVICE INFUSION ISSUE 12 0.0048
85 SKIN DISCOMFORT 13 0.0048
86 ECONOMIC PROBLEM 72 0.0047
87 SCAB 54 0.0047
88 NASAL DISCOMFORT 37 0.0047
89 BLOOD CHLORIDE DECREASED 12 0.0046
90 SQUAMOUS CELL CARCINOMA OF SKIN 28 0.0046
91 DERMATITIS ATOPIC 244 0.0046
92 ACTINIC KERATOSIS 12 0.0046
93 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 25 0.0046
94 MELANOCYTIC NAEVUS 20 0.0046
95 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 76 0.0045
96 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 316 0.0044
97 BLOOD IMMUNOGLOBULIN G DECREASED 11 0.0044
98 COLITIS ULCERATIVE 194 0.0043
99 PRODUCT PHYSICAL CONSISTENCY ISSUE 24 0.0043
100 INFUSION SITE HAEMORRHAGE 14 0.0043
101 TUBULOINTERSTITIAL NEPHRITIS 79 0.0042
102 PLANTAR FASCIITIS 14 0.0042
103 SUBCUTANEOUS ABSCESS 20 0.0042
104 HIDRADENITIS 38 0.0042
105 OSTEOPENIA 63 0.0041
106 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
107 PARONYCHIA 18 0.0041
108 WOUND SECRETION 16 0.0041
109 RENAL TUBULAR NECROSIS 40 0.0041
110 ARTHROPOD BITE 30 0.0040
111 SKIN EROSION 13 0.0040
112 INFUSION SITE ERYTHEMA 34 0.0040
113 UPPER-AIRWAY COUGH SYNDROME 33 0.0040
114 MACULE 11 0.0040
115 SKIN LACERATION 43 0.0040
116 PRODUCT ADMINISTRATION INTERRUPTED 31 0.0039
117 SCRATCH 41 0.0039
118 DERMATITIS CONTACT 43 0.0038
119 ABSCESS LIMB 16 0.0038
120 ANIMAL BITE 10 0.0037
121 HAEMATOCHEZIA 204 0.0037
122 NECROTISING FASCIITIS 13 0.0037
123 PRE-EXISTING CONDITION IMPROVED 23 0.0037
124 PRODUCT USE IN UNAPPROVED INDICATION 900 0.0036
125 INFUSION RELATED REACTION 239 0.0036
126 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 66 0.0036
127 EAR PAIN 70 0.0036
128 RHINOVIRUS INFECTION 14 0.0036
129 DERMATITIS 75 0.0036
130 SKIN LESION 98 0.0036
131 BLOOD BLISTER 11 0.0035
132 ODYNOPHAGIA 21 0.0035
133 NASAL DRYNESS 22 0.0035
134 INFUSION SITE SWELLING 22 0.0035
135 CONCUSSION 27 0.0035
136 SNORING 13 0.0034
137 RENAL FAILURE 455 0.0034
138 APPLICATION SITE SWELLING 17 0.0034
139 PARANASAL SINUS HYPERSECRETION 13 0.0034
140 RENAL INJURY 101 0.0034
141 TENDERNESS 35 0.0034
142 SKIN ULCER 86 0.0033
143 LOCALISED INFECTION 80 0.0033
144 SPINAL OSTEOARTHRITIS 29 0.0033
145 CELLULITIS 163 0.0032
146 PHARYNGITIS STREPTOCOCCAL 35 0.0032
147 HYPERCHLORHYDRIA 19 0.0032
148 FUNGAL SKIN INFECTION 13 0.0032
149 SECRETION DISCHARGE 40 0.0032
150 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 93 0.0032
151 BLOOD URIC ACID INCREASED 18 0.0031
152 HYPOPHOSPHATAEMIA 23 0.0031
153 SKIN SWELLING 27 0.0031
154 INFUSION SITE PAIN 40 0.0031
155 SKIN WARM 18 0.0031
156 SINUS DISORDER 61 0.0031
157 PIGMENTATION DISORDER 19 0.0031
158 INSURANCE ISSUE 47 0.0031
159 PURULENT DISCHARGE 13 0.0030
160 LIGAMENT SPRAIN 30 0.0030
161 PSEUDOMONAS INFECTION 26 0.0030
162 ACUTE RESPIRATORY FAILURE 58 0.0030
163 ACCIDENT 36 0.0030
164 EAR INFECTION 79 0.0030
165 DYSPEPSIA 291 0.0030
166 INCORRECT ROUTE OF DRUG ADMINISTRATION 105 0.0029
167 ECZEMA 153 0.0029
168 SINUSITIS 299 0.0029
169 CONJUNCTIVITIS 54 0.0029
170 FURUNCLE 23 0.0029
171 ENTEROCOCCAL INFECTION 14 0.0029
172 SQUAMOUS CELL CARCINOMA 27 0.0029
173 SCAR 49 0.0029
174 THERAPEUTIC PRODUCT EFFECT DELAYED 13 0.0028
175 ACUTE KIDNEY INJURY 436 0.0028
176 MUSCLE DISORDER 23 0.0028
177 HYPERVOLAEMIA 14 0.0028
178 SYNOVIAL CYST 13 0.0028
179 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
180 EXERCISE TOLERANCE DECREASED 16 0.0028
181 SINUS CONGESTION 37 0.0027
182 APPLICATION SITE DISCOLOURATION 11 0.0027
183 UPPER RESPIRATORY TRACT INFECTION 125 0.0027
184 RHINITIS ALLERGIC 12 0.0027
185 PERIPHERAL VENOUS DISEASE 11 0.0027
186 BLOOD MAGNESIUM DECREASED 23 0.0027
187 SPINAL STENOSIS 11 0.0027
188 EYE INFECTION 30 0.0027
189 LIMB INJURY 72 0.0026
190 STAPHYLOCOCCAL SEPSIS 13 0.0026
191 DIABETIC NEUROPATHY 13 0.0026
192 ATTENTION DEFICIT HYPERACTIVITY DISORDER 11 0.0026
193 THYROID MASS 10 0.0026
194 MAJOR DEPRESSION 19 0.0026
195 INTERCEPTED MEDICATION ERROR 12 0.0026
196 INCORRECT DRUG ADMINISTRATION RATE 11 0.0026
197 ROSACEA 12 0.0026
198 APPETITE DISORDER 17 0.0026
199 VITAMIN D DEFICIENCY 25 0.0026
200 DRUG ADMINISTERED AT INAPPROPRIATE SITE 27 0.0026
201 ESCHERICHIA INFECTION 21 0.0026
202 SKIN EXFOLIATION 215 0.0025
203 GASTROENTERITIS VIRAL 46 0.0025
204 PROSTATOMEGALY 10 0.0025
205 HAND FRACTURE 18 0.0025
206 HYPERKERATOSIS 14 0.0025
207 BACTERAEMIA 30 0.0025
208 PERIPHERAL VASCULAR DISORDER 13 0.0025
209 AZOTAEMIA 10 0.0025
210 FACIAL BONES FRACTURE 9 0.0025
211 ATELECTASIS 24 0.0025
212 WOUND 69 0.0025
213 CUTANEOUS VASCULITIS 9 0.0025
214 TOOTH ABSCESS 25 0.0025
215 ANAL INCONTINENCE 22 0.0024
216 ABSCESS 39 0.0024
217 HEPARIN-INDUCED THROMBOCYTOPENIA 12 0.0024
218 VASCULAR DEVICE INFECTION 11 0.0024
219 SCOLIOSIS 15 0.0024
220 IMPAIRED GASTRIC EMPTYING 33 0.0024
221 INFUSION SITE EXTRAVASATION 15 0.0024
222 SNEEZING 54 0.0024
223 PRODUCT PRESCRIBING ERROR 57 0.0024
224 BREAST MASS 16 0.0024
225 SKIN PLAQUE 20 0.0024
226 SKIN CANCER 51 0.0024
227 ORAL HERPES 46 0.0024
228 PHLEBITIS 12 0.0023
229 GASTROINTESTINAL INFECTION 21 0.0023
230 RESPIRATORY TRACT INFECTION 61 0.0023
231 RENAL FAILURE CHRONIC 18 0.0023
232 EPISTAXIS 175 0.0023
233 POST PROCEDURAL INFECTION 19 0.0023
234 DECUBITUS ULCER 19 0.0023
235 TOXIC EPIDERMAL NECROLYSIS 35 0.0023
236 IRON DEFICIENCY ANAEMIA 21 0.0023
237 SKIN ATROPHY 13 0.0023
238 POST-TRAUMATIC STRESS DISORDER 15 0.0022
239 MALNUTRITION 25 0.0022
240 SWELLING OF EYELID 14 0.0022
241 HOSPICE CARE 22 0.0022
242 FOOT FRACTURE 42 0.0022
243 RHINORRHOEA 142 0.0022
244 LUMBAR VERTEBRAL FRACTURE 10 0.0022
245 BLISTER 122 0.0022
246 GANGRENE 13 0.0022
247 ARTHRITIS INFECTIVE 10 0.0022
248 HEART RATE ABNORMAL 12 0.0021
249 SLEEP APNOEA SYNDROME 41 0.0021
250 NEPHROPATHY 20 0.0021
251 KIDNEY INFECTION 42 0.0021
252 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117 0.0021
253 TOOTH INFECTION 28 0.0021
254 PEMPHIGOID 16 0.0021
255 FAILURE TO THRIVE 11 0.0021
256 BASAL CELL CARCINOMA 33 0.0021
257 ARTERIOSCLEROSIS CORONARY ARTERY 14 0.0021
258 WOUND INFECTION 23 0.0021
259 SKIN MASS 14 0.0021
260 RIB FRACTURE 43 0.0021
261 MOUTH SWELLING 12 0.0021
262 DENTAL CARIES 23 0.0021
263 NASAL CONGESTION 122 0.0021
264 OSTEOARTHRITIS 88 0.0021
265 CLOSTRIDIUM DIFFICILE COLITIS 22 0.0021
266 POSTOPERATIVE WOUND INFECTION 14 0.0021
267 DYSPNOEA EXERTIONAL 78 0.0021
268 SKIN DISORDER 69 0.0021
269 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
270 INCREASED TENDENCY TO BRUISE 19 0.0021
271 DIVERTICULUM INTESTINAL 9 0.0021
272 HYPOVOLAEMIA 12 0.0020
273 GROIN PAIN 18 0.0020
274 ERYTHEMA 421 0.0020
275 ORAL DISORDER 15 0.0020
276 MOUTH HAEMORRHAGE 15 0.0020
277 WEIGHT DECREASED 571 0.0020
278 PHARYNGEAL SWELLING 20 0.0020
279 BONE DENSITY DECREASED 64 0.0020
280 PAIN OF SKIN 55 0.0020
281 FOREIGN BODY SENSATION IN EYES 13 0.0020
282 BACTERIAL INFECTION 38 0.0020
283 PRODUCT USE ISSUE 382 0.0020
284 BRONCHITIS 150 0.0020
285 FACIAL PAIN 18 0.0020
286 PULMONARY MASS 30 0.0020
287 HYPERNATRAEMIA 10 0.0020
288 OSTEOPOROSIS 82 0.0020
289 PRODUCTIVE COUGH 95 0.0020
290 CYSTIC FIBROSIS 11 0.0020
291 BRAIN FOG 31 0.0020
292 PRODUCT DOSE OMISSION IN ERROR 56 0.0020
293 KLEBSIELLA INFECTION 10 0.0020
294 THERMAL BURN 14 0.0020
295 SKIN DISCOLOURATION 90 0.0020
296 ANAEMIA 371 0.0019
297 FOOD ALLERGY 15 0.0019
298 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 12 0.0019
299 BLOOD IRON DECREASED 23 0.0019
300 POOR VENOUS ACCESS 20 0.0019
301 KNEE OPERATION 19 0.0019
302 DRY SKIN 257 0.0019
303 FLUID OVERLOAD 28 0.0019
304 WRIST FRACTURE 23 0.0019
305 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 13 0.0019
306 DRY EYE 95 0.0019
307 GASTROOESOPHAGEAL REFLUX DISEASE 153 0.0019
308 SENSITIVE SKIN 14 0.0019
309 GOUT 34 0.0019
310 NECK PAIN 105 0.0019
311 ORAL PAIN 42 0.0019
312 VITAMIN D DECREASED 16 0.0019
313 PATHOGEN RESISTANCE 17 0.0019
314 COVID-19 PNEUMONIA 22 0.0019
315 BLOOD POTASSIUM DECREASED 56 0.0019
316 FUNGAL INFECTION 62 0.0019
317 ANAL ABSCESS 10 0.0019
318 CYST 23 0.0019
319 APPLICATION SITE PRURITUS 42 0.0018
320 CONSTIPATION 402 0.0018
321 INTERVERTEBRAL DISC DEGENERATION 17 0.0018
322 CANDIDA INFECTION 31 0.0018
323 ABNORMAL FAECES 15 0.0018
324 RESPIRATORY TRACT CONGESTION 29 0.0018
325 OSTEOMYELITIS 33 0.0018
326 ABDOMINAL TENDERNESS 9 0.0018
327 PHOTOPHOBIA 34 0.0018
328 SPUTUM DISCOLOURED 17 0.0018
329 MENISCUS INJURY 11 0.0018
330 BRONCHIECTASIS 12 0.0018
331 PERIORBITAL SWELLING 10 0.0018
332 CHOLECYSTITIS ACUTE 10 0.0018
333 HIP ARTHROPLASTY 27 0.0018
334 DIZZINESS POSTURAL 17 0.0018
335 ECCHYMOSIS 12 0.0017
336 AUTOIMMUNE DISORDER 17 0.0017
337 ONYCHOCLASIS 12 0.0017
338 RHINITIS 14 0.0017
339 HERPES VIRUS INFECTION 10 0.0017
340 LYMPHOEDEMA 12 0.0017
341 EYE DISCHARGE 18 0.0017
342 THERAPY PARTIAL RESPONDER 27 0.0017
343 ILLNESS 178 0.0017
344 PRODUCT DISTRIBUTION ISSUE 16 0.0017
345 HERPES ZOSTER 99 0.0017
346 TRANSFUSION 18 0.0017
347 APPLICATION SITE ERYTHEMA 45 0.0017
348 VASCULITIS 20 0.0017
349 TOOTHACHE 31 0.0017
350 RASH PRURITIC 92 0.0017
351 HERPES SIMPLEX 11 0.0017
352 IMMUNE SYSTEM DISORDER 22 0.0017
353 ABDOMINAL PAIN 387 0.0017
354 CARDIAC FAILURE ACUTE 11 0.0016
355 RASH PUSTULAR 12 0.0016
356 INGUINAL HERNIA 10 0.0016
357 CHOLECYSTITIS CHRONIC 11 0.0016
358 HYPOPHAGIA 42 0.0016
359 CARPAL TUNNEL SYNDROME 23 0.0016
360 ROTATOR CUFF SYNDROME 21 0.0016
361 ATRIAL FLUTTER 13 0.0016
362 PRURITUS 626 0.0016
363 SPINAL OPERATION 20 0.0016
364 VIRAL INFECTION 54 0.0016
365 HIATUS HERNIA 21 0.0016
366 HYPOXIA 57 0.0016
367 CARDIAC MURMUR 14 0.0016
368 SLEEP DISORDER 114 0.0016
369 ANKLE FRACTURE 25 0.0016
370 INTENTIONAL DOSE OMISSION 46 0.0016
371 BLOOD UREA INCREASED 27 0.0016
372 PERIPHERAL SWELLING 248 0.0016
373 EYE PRURITUS 54 0.0016
374 RASH MACULAR 56 0.0016
375 FLANK PAIN 15 0.0016
376 IMPAIRED QUALITY OF LIFE 23 0.0016
377 URINARY TRACT INFECTION 272 0.0016
378 HYPERLIPIDAEMIA 19 0.0016
379 MULTIPLE INJURIES 10 0.0016
380 PULMONARY HYPERTENSION 33 0.0016
381 HEAD INJURY 50 0.0016
382 CHOLECYSTECTOMY 18 0.0016
383 NEPHROLITHIASIS 72 0.0016
384 PYREXIA 543 0.0016
385 PROCTALGIA 10 0.0016
386 SURGERY 91 0.0016
387 DIVERTICULUM 11 0.0015
388 JOINT INJURY 33 0.0015
389 FEAR OF INJECTION 11 0.0015
390 PELVIC FRACTURE 12 0.0015
391 THROAT IRRITATION 69 0.0015
392 CONTUSION 148 0.0015
393 GENERALISED OEDEMA 19 0.0015
394 PSORIASIS 200 0.0015
395 FOLLICULITIS 16 0.0015
396 PAIN 932 0.0015
397 OEDEMA 82 0.0015
398 BURNING SENSATION 106 0.0015
399 RENAL CYST 12 0.0015
400 TRICUSPID VALVE INCOMPETENCE 12 0.0015
401 DYSSTASIA 44 0.0015
402 MITRAL VALVE INCOMPETENCE 17 0.0015
403 OXYGEN SATURATION DECREASED 84 0.0015
404 INJECTION SITE IRRITATION 19 0.0015
405 DYSPHONIA 87 0.0015
406 NAIL DISORDER 13 0.0015
407 BURSITIS 18 0.0015
408 DECREASED ACTIVITY 16 0.0015
409 BONE DISORDER 27 0.0015
410 NEURALGIA 36 0.0015
411 TASTE DISORDER 30 0.0015
412 BACK DISORDER 24 0.0015
413 CYSTITIS 47 0.0015
414 BIPOLAR DISORDER 16 0.0015
415 OROPHARYNGEAL PAIN 136 0.0015
416 WHEEZING 87 0.0015
417 EXPOSURE VIA SKIN CONTACT 38 0.0015
418 RESPIRATORY RATE INCREASED 13 0.0015
419 EMOTIONAL DISTRESS 177 0.0015
420 IMPAIRED HEALING 48 0.0015
421 PAROSMIA 11 0.0015
422 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 76 0.0015
423 FLUID RETENTION 74 0.0015
424 MUCOSAL INFLAMMATION 38 0.0014
425 PULMONARY ARTERIAL HYPERTENSION 21 0.0014
426 SCIATICA 23 0.0014
427 DISCOMFORT 88 0.0014
428 RASH 628 0.0014
429 MATERNAL DRUGS AFFECTING FOETUS 11 0.0014
430 BLOOD SODIUM DECREASED 27 0.0014
431 PNEUMONIA 462 0.0014
432 INFECTION 205 0.0014
433 HYPOALBUMINAEMIA 11 0.0014
434 COUGH 396 0.0014
435 HAEMATOCRIT DECREASED 28 0.0014
436 ROAD TRAFFIC ACCIDENT 59 0.0014
437 UROSEPSIS 13 0.0014
438 COVID-19 246 0.0014
439 ADRENAL INSUFFICIENCY 17 0.0014
440 INTERNAL HAEMORRHAGE 16 0.0014
441 IRRITABLE BOWEL SYNDROME 30 0.0014
442 PRODUCT DOSE OMISSION ISSUE 411 0.0014
443 NIGHT SWEATS 45 0.0014
444 CARDIAC OPERATION 12 0.0014
445 MUSCULOSKELETAL DISCOMFORT 24 0.0014
446 MIGRAINE 133 0.0014
447 PSYCHOLOGICAL TRAUMA 12 0.0014
448 ANXIETY 395 0.0014
449 BLOOD ALBUMIN DECREASED 11 0.0014
450 ENCEPHALOPATHY 34 0.0014
451 CARDIOMEGALY 17 0.0014
452 LEUKOCYTOSIS 25 0.0014
453 DERMATITIS BULLOUS 10 0.0014
454 CONDITION AGGRAVATED 420 0.0014
455 PSORIATIC ARTHROPATHY 56 0.0014
456 NODULE 18 0.0014
457 NEUROPATHY PERIPHERAL 131 0.0014
458 OCULAR HYPERAEMIA 65 0.0014
459 APPLICATION SITE IRRITATION 17 0.0014
460 EYE PAIN 77 0.0014
461 TOOTH FRACTURE 15 0.0014
462 PRODUCT COMMUNICATION ISSUE 12 0.0014
463 RASH ERYTHEMATOUS 65 0.0014
464 SEPTIC SHOCK 59 0.0014
465 EYE IRRITATION 78 0.0014
466 LOWER LIMB FRACTURE 26 0.0014
467 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 65 0.0014
468 TOOTH DISORDER 30 0.0013
469 NERVE INJURY 15 0.0013
470 HYPERCHOLESTEROLAEMIA 13 0.0013
471 MALIGNANT MELANOMA 18 0.0013
472 SUNBURN 10 0.0013
473 WEIGHT FLUCTUATION 14 0.0013
474 SEPSIS 149 0.0013
475 STOMATITIS 81 0.0013
476 JOINT STIFFNESS 35 0.0013
477 BLOOD ALKALINE PHOSPHATASE INCREASED 33 0.0013
478 CLOSTRIDIUM DIFFICILE INFECTION 29 0.0013
479 INFLUENZA 148 0.0013
480 THERAPEUTIC RESPONSE SHORTENED 44 0.0013
481 INCONTINENCE 14 0.0013
482 FIBROMYALGIA 32 0.0013
483 TROPONIN INCREASED 10 0.0013
484 EXOSTOSIS 12 0.0013
485 BODY HEIGHT DECREASED 14 0.0013
486 OEDEMA PERIPHERAL 159 0.0013
487 WHITE BLOOD CELL COUNT INCREASED 50 0.0013
488 DROOLING 9 0.0013
489 GASTROENTERITIS 19 0.0013
490 DRUG PRESCRIBING ERROR 25 0.0013
491 GLAUCOMA 25 0.0013
492 ASTHMA 146 0.0013
493 MASS 18 0.0013
494 BACK INJURY 14 0.0013
495 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
496 SARS-COV-2 TEST POSITIVE 17 0.0013
497 CARDIOMYOPATHY 19 0.0013
498 SKIN HYPERPIGMENTATION 11 0.0013
499 MULTIPLE FRACTURES 21 0.0013
500 MUSCLE STRAIN 11 0.0013
501 QUALITY OF LIFE DECREASED 17 0.0013
502 SPINAL DISORDER 12 0.0013
503 EAR DISCOMFORT 13 0.0013
504 MUSCLE ATROPHY 16 0.0013
505 PRODUCT PACKAGING ISSUE 12 0.0013
506 RED BLOOD CELL COUNT DECREASED 36 0.0013
507 URINE OUTPUT DECREASED 11 0.0013
508 ULCER 20 0.0013
509 HYPERSOMNIA 36 0.0013
510 OBESITY 20 0.0013
511 CORONARY ARTERY DISEASE 38 0.0013
512 HYPERKALAEMIA 44 0.0013
513 POOR QUALITY SLEEP 27 0.0013
514 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 225 0.0012
515 SPINAL FRACTURE 25 0.0012
516 OCULAR DISCOMFORT 14 0.0012
517 POLLAKIURIA 52 0.0012
518 FISTULA 14 0.0012
519 BLOOD CALCIUM DECREASED 14 0.0012
520 PNEUMONIA ASPIRATION 31 0.0012
521 DECREASED APPETITE 288 0.0012
522 SWELLING 116 0.0012
523 EXPIRED PRODUCT ADMINISTERED 41 0.0012
524 HEADACHE 773 0.0012
525 MUSCULOSKELETAL CHEST PAIN 19 0.0012
526 GAIT INABILITY 41 0.0012
527 LACRIMATION INCREASED 37 0.0012
528 CEREBRAL DISORDER 9 0.0012
529 PHARYNGITIS 15 0.0012
530 ILEUS 15 0.0012
531 TOOTH LOSS 25 0.0012
532 ELECTROLYTE IMBALANCE 14 0.0012
533 NAUSEA 953 0.0012
534 LETHARGY 69 0.0012
535 PNEUMONIA BACTERIAL 11 0.0012
536 POST PROCEDURAL COMPLICATION 23 0.0012
537 SINUS TACHYCARDIA 17 0.0012
538 ARTHRITIS 94 0.0012
539 OESOPHAGITIS 13 0.0012
540 PERITONITIS BACTERIAL 12 0.0012
541 EYE SWELLING 44 0.0012
542 PRODUCT DOSE OMISSION 77 0.0012
543 BLOOD CREATININE INCREASED 77 0.0012
544 GALLBLADDER DISORDER 21 0.0012
545 MALAISE 515 0.0012
546 EATING DISORDER 25 0.0012
547 FALL 390 0.0012
548 COMPLICATION ASSOCIATED WITH DEVICE 17 0.0012
549 LACERATION 11 0.0012
550 DEVICE RELATED INFECTION 18 0.0012
551 ARTERIOSCLEROSIS 11 0.0012
552 RESPIRATORY FAILURE 85 0.0012
553 APHTHOUS ULCER 9 0.0012
554 RESPIRATORY DISTRESS 32 0.0012
555 BLOOD URINE PRESENT 22 0.0012
556 SKIN IRRITATION 53 0.0012
557 DRUG INEFFECTIVE 1523 0.0012
558 RESTLESS LEGS SYNDROME 21 0.0012
559 PYELONEPHRITIS 10 0.0012
560 BACK PAIN 268 0.0012
561 MENTAL STATUS CHANGES 32 0.0012
562 ATRIAL FIBRILLATION 112 0.0011
563 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
564 HAEMOPTYSIS 32 0.0011
565 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
566 INTERVERTEBRAL DISC PROTRUSION 25 0.0011
567 CYTOPENIA 14 0.0011
568 IMMUNODEFICIENCY 17 0.0011
569 COAGULOPATHY 19 0.0011
570 RESPIRATORY DISORDER 34 0.0011
571 LIMB DISCOMFORT 35 0.0011
572 DEPRESSION 257 0.0011
573 OFF LABEL USE 988 0.0011
574 HAEMORRHOIDS 22 0.0011
575 TOOTH EXTRACTION 14 0.0011
576 DIVERTICULITIS 31 0.0011
577 PLEURAL EFFUSION 68 0.0011
578 RASH PAPULAR 25 0.0011
579 CARDIOGENIC SHOCK 16 0.0011
580 DERMATITIS ALLERGIC 14 0.0011
581 UNEVALUABLE EVENT 84 0.0011
582 SPINAL PAIN 13 0.0011
583 OROPHARYNGEAL DISCOMFORT 10 0.0011
584 BLOOD PRESSURE ABNORMAL 22 0.0011
585 DIARRHOEA 712 0.0011
586 PULMONARY THROMBOSIS 12 0.0011
587 BLOOD PRESSURE INCREASED 168 0.0011
588 GINGIVAL BLEEDING 15 0.0011
589 ASPIRATION 12 0.0011
590 RENAL IMPAIRMENT 92 0.0011
591 PAIN IN JAW 31 0.0011
592 MOUTH ULCERATION 23 0.0011
593 EMPHYSEMA 11 0.0011
594 ARTHRALGIA 453 0.0011
595 PROSTATIC SPECIFIC ANTIGEN INCREASED 15 0.0011
596 PRODUCT ADMINISTRATION ERROR 22 0.0011
597 HIP FRACTURE 35 0.0011
598 BLOOD THYROID STIMULATING HORMONE INCREASED 10 0.0011
599 DYSURIA 40 0.0011
600 INFLAMMATION 56 0.0011
601 NERVE COMPRESSION 10 0.0011
602 CARDIAC FAILURE CONGESTIVE 87 0.0011
603 HEART RATE INCREASED 107 0.0011
604 EOSINOPHIL COUNT INCREASED 9 0.0011
605 DRUG EFFECT LESS THAN EXPECTED 16 0.0011
606 DEHYDRATION 144 0.0011
607 HYPOMAGNESAEMIA 15 0.0011
608 FLATULENCE 61 0.0011
609 APHONIA 15 0.0011
610 HEAD DISCOMFORT 19 0.0011
611 INITIAL INSOMNIA 11 0.0011
612 THERAPEUTIC RESPONSE DECREASED 65 0.0011
613 LIVER FUNCTION TEST INCREASED 23 0.0011
614 WHITE BLOOD CELL COUNT DECREASED 116 0.0011
615 CHOLELITHIASIS 35 0.0011
616 MUSCULAR WEAKNESS 121 0.0011
617 GASTRITIS 28 0.0011
618 FATIGUE 827 0.0011
619 DEEP VEIN THROMBOSIS 69 0.0011
620 HYPOKALAEMIA 49 0.0011
621 MUSCLE SPASTICITY 13 0.0011
622 FEBRILE NEUTROPENIA 70 0.0011
623 UPPER LIMB FRACTURE 21 0.0011
624 PALPITATIONS 123 0.0010
625 SUBDURAL HAEMATOMA 15 0.0010
626 BLOOD POTASSIUM INCREASED 17 0.0010
627 DRUG DISPENSING ERROR 16 0.0010
628 INJECTION SITE SWELLING 79 0.0010
629 BLOOD PRESSURE SYSTOLIC INCREASED 20 0.0010
630 HEREDITARY ANGIOEDEMA 11 0.0010
631 CYTOMEGALOVIRUS INFECTION 17 0.0010
632 PANCYTOPENIA 57 0.0010
633 THINKING ABNORMAL 19 0.0010
634 BALANCE DISORDER 88 0.0010
635 PAIN IN EXTREMITY 298 0.0010
636 MENTAL DISORDER 44 0.0010
637 MUSCLE SPASMS 185 0.0010
638 CATARACT 60 0.0010
639 THERAPY INTERRUPTED 72 0.0010
640 ORAL DISCOMFORT 14 0.0010
641 PULMONARY OEDEMA 45 0.0010
642 HYPOCALCAEMIA 19 0.0010
643 HYPOAESTHESIA 150 0.0010
644 BLOOD PRESSURE FLUCTUATION 24 0.0010
645 SALIVARY HYPERSECRETION 10 0.0010
646 NASOPHARYNGITIS 184 0.0010
647 ASTHENIA 375 0.0010
648 MEMORY IMPAIRMENT 137 0.0010
649 JOINT SWELLING 120 0.0010
650 BLOOD PRESSURE DECREASED 66 0.0010
651 MUSCULOSKELETAL PAIN 52 0.0010
652 FULL BLOOD COUNT DECREASED 20 0.0010
653 DYSPHAGIA 94 0.0010
654 BLOOD COUNT ABNORMAL 15 0.0010
655 SEIZURE 114 0.0010
656 SWELLING FACE 64 0.0010
657 HOSPITALISATION 151 0.0010
658 LABORATORY TEST ABNORMAL 29 0.0010
659 HERNIA 19 0.0010
660 INTESTINAL OBSTRUCTION 37 0.0010
661 MOTOR DYSFUNCTION 10 0.0010
662 URINARY INCONTINENCE 29 0.0010
663 ABDOMINAL DISCOMFORT 164 0.0010
664 URTICARIA 163 0.0010
665 GAIT DISTURBANCE 186 0.0010
666 FEELING COLD 27 0.0010
667 TEMPERATURE INTOLERANCE 10 0.0010
668 HEPATIC STEATOSIS 18 0.0010
669 PERITONITIS 20 0.0010
670 PRODUCT DISPENSING ERROR 21 0.0010
671 MICTURITION URGENCY 11 0.0010
672 DYSPNOEA 545 0.0010
673 AGEUSIA 24 0.0010
674 PETECHIAE 10 0.0010
675 NEOPLASM 11 0.0010
676 DEAFNESS 25 0.0010
677 MELAENA 21 0.0010
678 PRESCRIBED UNDERDOSE 19 0.0010
679 INJECTION SITE DISCOMFORT 10 0.0009
680 POOR QUALITY PRODUCT ADMINISTERED 10 0.0009
681 VISION BLURRED 130 0.0009
682 POST PROCEDURAL HAEMORRHAGE 11 0.0009
683 THROMBOSIS 76 0.0009
684 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 22 0.0009
685 WEIGHT INCREASED 210 0.0009
686 FEEDING DISORDER 19 0.0009
687 DRY MOUTH 76 0.0009
688 THERAPEUTIC RESPONSE UNEXPECTED 42 0.0009
689 TINNITUS 43 0.0009
690 LIP SWELLING 31 0.0009
691 FEAR 25 0.0009
692 HYPOAESTHESIA ORAL 14 0.0009
693 INJURY 65 0.0009
694 ASPARTATE AMINOTRANSFERASE INCREASED 49 0.0009
695 VISUAL IMPAIRMENT 114 0.0009
696 ASCITES 27 0.0009
697 MULTIPLE ORGAN DYSFUNCTION SYNDROME 26 0.0009
698 INJECTION SITE RASH 28 0.0009
699 THERAPY NON-RESPONDER 41 0.0009
700 DISABILITY 18 0.0009
701 ABDOMINAL DISTENSION 95 0.0009
702 BLOOD TRIGLYCERIDES INCREASED 16 0.0009
703 ADVERSE DRUG REACTION 81 0.0009
704 ANOSMIA 13 0.0009
705 CHEST PAIN 166 0.0009
706 DISEASE PROGRESSION 106 0.0009
707 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
708 JOINT RANGE OF MOTION DECREASED 12 0.0009
709 MYALGIA 152 0.0009
710 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
711 UNRESPONSIVE TO STIMULI 23 0.0009
712 INCORRECT DRUG ADMINISTRATION DURATION 25 0.0009
713 HYPERTENSION 188 0.0009
714 VERTIGO 54 0.0009
715 DRY THROAT 9 0.0009
716 PNEUMOTHORAX 14 0.0009
717 HYPOTENSION 177 0.0009
718 EYE DISORDER 29 0.0009
719 PLATELET COUNT DECREASED 94 0.0009
720 CRYING 32 0.0009
721 INJECTION SITE DISCOLOURATION 11 0.0009
722 MYOCARDIAL ISCHAEMIA 10 0.0009
723 ERUCTATION 17 0.0009
724 NO ADVERSE EVENT 159 0.0009
725 HYPOTHYROIDISM 28 0.0009
726 GASTROINTESTINAL HAEMORRHAGE 73 0.0009
727 ACCIDENTAL EXPOSURE TO PRODUCT 90 0.0009
728 CHOKING 17 0.0009
729 ANAPHYLACTIC REACTION 48 0.0009
730 HALLUCINATION 65 0.0009
731 CHILLS 101 0.0009
732 ALOPECIA 169 0.0009
733 RENAL DISORDER 40 0.0009
734 SPLENOMEGALY 10 0.0009
735 SKIN REACTION 12 0.0009
736 ABDOMINAL PAIN UPPER 175 0.0008
737 THROMBOCYTOPENIA 95 0.0008
738 LYMPHOCYTE COUNT DECREASED 15 0.0008
739 PHOTOSENSITIVITY REACTION 14 0.0008
740 HAEMOGLOBIN DECREASED 87 0.0008
741 DIALYSIS 12 0.0008
742 RETCHING 18 0.0008
743 PLATELET COUNT INCREASED 11 0.0008
744 CHEST DISCOMFORT 86 0.0008
745 TENDONITIS 13 0.0008
746 DIABETES MELLITUS 64 0.0008
747 DIZZINESS 418 0.0008
748 GASTROINTESTINAL DISORDER 75 0.0008
749 BONE PAIN 49 0.0008
750 EJECTION FRACTION DECREASED 13 0.0008
751 ANKYLOSING SPONDYLITIS 11 0.0008
752 SWOLLEN TONGUE 26 0.0008
753 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
754 TRANSIENT ISCHAEMIC ATTACK 28 0.0008
755 ARTHROPATHY 46 0.0008
756 HYPOKINESIA 12 0.0008
757 TREATMENT NONCOMPLIANCE 45 0.0008
758 HAEMATOMA 21 0.0008
759 INSOMNIA 215 0.0008
760 EXTRAPYRAMIDAL DISORDER 20 0.0008
761 RENAL FAILURE ACUTE 34 0.0008
762 BONE LOSS 12 0.0008
763 HEART RATE IRREGULAR 18 0.0008
764 PRODUCT AVAILABILITY ISSUE 18 0.0008
765 HYPOACUSIS 34 0.0008
766 GASTRIC ULCER 15 0.0008
767 FEELING ABNORMAL 189 0.0008
768 HAEMATURIA 27 0.0008
769 INTENTIONAL PRODUCT USE ISSUE 69 0.0008
770 VENTRICULAR TACHYCARDIA 13 0.0008
771 GASTRIC DISORDER 27 0.0008
772 NEUTROPHIL COUNT DECREASED 32 0.0008
773 INCORRECT PRODUCT ADMINISTRATION DURATION 17 0.0008
774 BODY TEMPERATURE INCREASED 16 0.0008
775 FAECES DISCOLOURED 17 0.0008
776 PARAESTHESIA 123 0.0008
777 LYMPHOMA 12 0.0008
778 LUNG INFECTION 12 0.0008
779 BRONCHOSPASM 11 0.0008
780 INTENTIONAL PRODUCT MISUSE 67 0.0008
781 INJECTION SITE PAIN 234 0.0008
782 LYMPHADENOPATHY 27 0.0008
783 INJECTION SITE PRURITUS 51 0.0008
784 VOMITING 357 0.0008
785 RHEUMATOID ARTHRITIS 86 0.0008
786 CARDIAC ARREST 62 0.0008
787 INJECTION SITE ERYTHEMA 93 0.0007
788 ALANINE AMINOTRANSFERASE INCREASED 46 0.0007
789 ORTHOSTATIC HYPOTENSION 13 0.0007
790 FEMUR FRACTURE 23 0.0007
791 TYPE 2 DIABETES MELLITUS 25 0.0007
792 TREMOR 123 0.0007
793 PANIC ATTACK 27 0.0007
794 MUSCLE TIGHTNESS 12 0.0007
795 HEART RATE DECREASED 26 0.0007
796 SYNCOPE 74 0.0007
797 ACNE 56 0.0007
798 PANCREATITIS 39 0.0007
799 BRADYCARDIA 39 0.0007
800 DRUG ERUPTION 13 0.0007
801 OSTEONECROSIS 24 0.0007
802 PRODUCT PREPARATION ERROR 15 0.0007
803 SOMNOLENCE 147 0.0007
804 HOT FLUSH 55 0.0007
805 BLOOD CHOLESTEROL INCREASED 34 0.0007
806 CORONARY ARTERY OCCLUSION 10 0.0007
807 PERIPHERAL COLDNESS 10 0.0007
808 HYPONATRAEMIA 41 0.0007
809 HYPERSENSITIVITY 135 0.0007
810 TREATMENT FAILURE 60 0.0007
811 DYSARTHRIA 27 0.0007
812 LUNG DISORDER 35 0.0007
813 EMOTIONAL DISORDER 22 0.0007
814 BRAIN OEDEMA 9 0.0007
815 KNEE ARTHROPLASTY 15 0.0007
816 ABDOMINAL PAIN LOWER 18 0.0007
817 MOBILITY DECREASED 51 0.0007
818 BLOOD BILIRUBIN INCREASED 19 0.0007
819 MOOD ALTERED 19 0.0007
820 APHASIA 21 0.0007
821 MULTI-ORGAN FAILURE 12 0.0007
822 MUSCLE TWITCHING 16 0.0007
823 DIPLOPIA 18 0.0007
824 INJECTION SITE URTICARIA 17 0.0007
825 C-REACTIVE PROTEIN INCREASED 25 0.0007
826 FRACTURE 13 0.0007
827 DRUG INTOLERANCE 66 0.0007
828 MUSCULOSKELETAL DISORDER 13 0.0007
829 LOSS OF CONSCIOUSNESS 87 0.0007
830 NEUTROPENIA 92 0.0007
831 TACHYCARDIA 60 0.0007
832 CARDIAC FAILURE 54 0.0007
833 GLOSSODYNIA 15 0.0007
834 SPEECH DISORDER 35 0.0007
835 HYPERHIDROSIS 86 0.0007
836 THERAPY CESSATION 34 0.0007
837 MUSCULOSKELETAL STIFFNESS 58 0.0007
838 PALLOR 18 0.0007
839 AMNESIA 43 0.0007
840 HAEMORRHAGE 69 0.0007
841 PRESYNCOPE 16 0.0007
842 CARDIAC DISORDER 61 0.0007
843 ANGER 22 0.0006
844 PHARYNGEAL OEDEMA 10 0.0006
845 COORDINATION ABNORMAL 9 0.0006
846 ACUTE MYOCARDIAL INFARCTION 19 0.0006
847 DELUSION 10 0.0006
848 MIDDLE INSOMNIA 12 0.0006
849 BLOOD TEST ABNORMAL 9 0.0006
850 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
851 BLINDNESS UNILATERAL 9 0.0006
852 PRODUCT USE COMPLAINT 10 0.0006
853 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
854 HALLUCINATION, AUDITORY 10 0.0006
855 ANGINA PECTORIS 18 0.0006
856 SKIN BURNING SENSATION 45 0.0006
857 INJECTION SITE BRUISING 50 0.0006
858 CONFUSIONAL STATE 101 0.0006
859 INJECTION SITE REACTION 43 0.0006
860 BLOOD GLUCOSE DECREASED 30 0.0006
861 INJECTION SITE MASS 23 0.0006
862 FEELING HOT 38 0.0006
863 DYSGEUSIA 46 0.0006
864 HALLUCINATION, VISUAL 13 0.0006
865 PLASMA CELL MYELOMA 24 0.0006
866 PULMONARY EMBOLISM 58 0.0006
867 SHOCK 14 0.0006
868 DEMENTIA 17 0.0006
869 PERICARDIAL EFFUSION 14 0.0006
870 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
871 HYPERGLYCAEMIA 22 0.0006
872 COGNITIVE DISORDER 28 0.0006
873 SYSTEMIC LUPUS ERYTHEMATOSUS 21 0.0006
874 THROAT TIGHTNESS 16 0.0006
875 ARRHYTHMIA 28 0.0006
876 CIRCULATORY COLLAPSE 10 0.0006
877 DEPRESSED MOOD 31 0.0006
878 STEVENS-JOHNSON SYNDROME 13 0.0006
879 PANCREATITIS ACUTE 13 0.0006
880 ACUTE MYELOID LEUKAEMIA 9 0.0006
881 FEELING JITTERY 11 0.0006
882 COLD SWEAT 10 0.0006
883 METABOLIC ACIDOSIS 18 0.0006
884 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
885 MOVEMENT DISORDER 18 0.0006
886 PRURITUS GENERALISED 12 0.0006
887 PNEUMONITIS 15 0.0006
888 INFLUENZA LIKE ILLNESS 45 0.0005
889 SUICIDAL IDEATION 50 0.0005
890 DRUG RESISTANCE 14 0.0005
891 ILL-DEFINED DISORDER 33 0.0005
892 URINARY RETENTION 18 0.0005
893 HEPATIC CIRRHOSIS 10 0.0005
894 IRRITABILITY 32 0.0005
895 NEOPLASM MALIGNANT 35 0.0005
896 INCREASED APPETITE 10 0.0005
897 DRUG EFFECT INCOMPLETE 19 0.0005
898 DISTURBANCE IN ATTENTION 28 0.0005
899 DEATH 447 0.0005
900 DRUG INTERACTION 82 0.0005
901 GLYCOSYLATED HAEMOGLOBIN INCREASED 13 0.0005
902 HAEMATEMESIS 13 0.0005
903 CARDIOVASCULAR DISORDER 13 0.0005
904 ADVERSE EVENT 47 0.0005
905 PSYCHOTIC DISORDER 15 0.0005
906 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
907 MOOD SWINGS 16 0.0005
908 CEREBROVASCULAR ACCIDENT 85 0.0005
909 MENTAL IMPAIRMENT 12 0.0005
910 DEVICE BREAKAGE 20 0.0005
911 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 35 0.0005
912 LIVER INJURY 12 0.0005
913 BLOOD GLUCOSE ABNORMAL 9 0.0005
914 INJECTION SITE WARMTH 10 0.0005
915 HEPATIC ENZYME INCREASED 33 0.0005
916 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 97 0.0005
917 NERVOUSNESS 25 0.0005
918 MALIGNANT NEOPLASM PROGRESSION 49 0.0005
919 MYELOSUPPRESSION 17 0.0005
920 ABNORMAL DREAMS 13 0.0005
921 HEPATITIS 12 0.0005
922 DYSKINESIA 19 0.0005
923 NIGHTMARE 16 0.0005
924 CARDIO-RESPIRATORY ARREST 19 0.0005
925 RASH MACULO-PAPULAR 10 0.0004
926 AGITATION 33 0.0004
927 NERVOUS SYSTEM DISORDER 14 0.0004
928 BLOOD GLUCOSE INCREASED 84 0.0004
929 MULTIPLE SCLEROSIS 21 0.0004
930 HYPOGLYCAEMIA 21 0.0004
931 FLUSHING 44 0.0004
932 DRUG ADMINISTRATION ERROR 13 0.0004
933 DEVICE ISSUE 37 0.0004
934 NEEDLE ISSUE 12 0.0004
935 RESTLESSNESS 15 0.0004
936 LIVER DISORDER 18 0.0004
937 DISORIENTATION 16 0.0004
938 DELIRIUM 14 0.0004
939 NEOPLASM PROGRESSION 14 0.0004
940 LEUKOPENIA 20 0.0004
941 GENERAL PHYSICAL HEALTH DETERIORATION 46 0.0004
942 EXTRA DOSE ADMINISTERED 16 0.0004
943 BLINDNESS 16 0.0004
944 VISUAL ACUITY REDUCED 13 0.0004
945 ERECTILE DYSFUNCTION 10 0.0004
946 INCORRECT DOSE ADMINISTERED 87 0.0004
947 WITHDRAWAL SYNDROME 16 0.0004
948 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
949 DIABETIC KETOACIDOSIS 9 0.0004
950 VAGINAL HAEMORRHAGE 16 0.0004
951 DEVICE DISLOCATION 16 0.0004
952 CEREBRAL HAEMORRHAGE 13 0.0004
953 DRUG DOSE OMISSION 60 0.0004
954 RESPIRATORY ARREST 10 0.0004
955 ANGIOEDEMA 16 0.0004
956 MYOCARDIAL INFARCTION 61 0.0003
957 MATERNAL EXPOSURE DURING PREGNANCY 31 0.0003
958 DEVICE LEAKAGE 15 0.0003
959 LIVER FUNCTION TEST ABNORMAL 10 0.0003
960 PRODUCT STORAGE ERROR 30 0.0003
961 INTERSTITIAL LUNG DISEASE 16 0.0003
962 UNDERDOSE 24 0.0003
963 ABNORMAL BEHAVIOUR 13 0.0003
964 LUNG NEOPLASM MALIGNANT 13 0.0003
965 ACCIDENTAL OVERDOSE 11 0.0003
966 INJECTION SITE HAEMORRHAGE 24 0.0003
967 RHABDOMYOLYSIS 12 0.0003
968 PRODUCT QUALITY ISSUE 39 0.0003
969 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
970 DRUG DEPENDENCE 45 0.0003
971 ABORTION SPONTANEOUS 11 0.0003
972 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
973 SUICIDE ATTEMPT 16 0.0003
974 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 12 0.0003
975 DEVICE MALFUNCTION 18 0.0003
976 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
977 MULTIPLE SCLEROSIS RELAPSE 17 0.0002
978 OVERDOSE 53 0.0002
979 PRODUCT SUBSTITUTION ISSUE 14 0.0002
980 EXPOSURE DURING PREGNANCY 15 0.0002
981 MEDICATION ERROR 13 0.0002
982 DISEASE RECURRENCE 11 0.0002
983 DRUG WITHDRAWAL SYNDROME 20 0.0002
984 AGGRESSION 11 0.0002
985 DRUG EFFECT DECREASED 11 0.0002
986 CONVULSION 11 0.0002
987 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
988 TOXICITY TO VARIOUS AGENTS 22 0.0001
989 DRUG ABUSE 9 0.0001
990 BREAST CANCER 10 0.0001